Luminex Assay Principle

 

Multiplex Luminex Assay Principle Step 1: The sample is added to color-coded beads, pre-coated with analyte-specific capture antibodies. Biotinylated detection antibodies are added and form an antibody-antigen sandwich.
The sample is added to a mixture of color-coded beads, pre-coated with analyte-specific capture antibodies. The antibodies bind to the analytes of interest. Biotinylated detection antibodies specific to the analytes of interest are added and form an antibody-antigen sandwich. Phycoerythrin (PE)-conjugated streptavidin is added. It binds to the biotinylated detection antibodies.

 

Beads are read on a dual-laser flow-based detection instrument.

Beads are read on a dual-laser flow-based detection instrument, such as the Luminex 200 or FlexMap® analyzer. One laser classifies the bead and determines the analyte that is being detected. The second laser determines the magnitude of the PE-derived signal, which is in direct proportion to the amount of analyte bound.

In addition to flow-based analyzers, the xMAP INTELLIFLEX® is an advanced multiplexing instrument that offers automation capabilities. It boasts a compact design with a reduced footprint and a wide dynamic range, providing powerful performance. The instrument enables the simultaneous detection of up to 500 analytes in a single sample volume and offers high sensitivity and accuracy.

 

 

Find Your Luminex® Answers

R&D Systems’ Luminex assays have the largest, most flexible Luminex analyte available.  With our menu of off-the-shelf fixed panels, high-performance configurable panels, and completely custom panels, we have options to best fit your needs, ensuring you get the most data from your samples with results you can trust.

Build your Luminex assay by analyte Choose your Luminex panel Custom Luminex Services Luminex Instruments
Build by Analyte Choose by Panel Custom Projects Luminex Instruments
 

 

 Luminex®, Luminex 200™, Luminex xMAP INTELLIFLEX®, and FlexMap® are trademarks of Luminex Corporation.